Papers
2
Total Citations
96
H-Index
2
About
Daisy Elliott is a leading clinical researcher whose work centers on surgical innovation and patient-reported outcomes, with a particular focus on thoracic and head-and-neck oncology. Her most impactful contribution is the landmark VIOLET randomized controlled trial (2022, 88 citations), which rigorously compared video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer. By prioritizing self-reported physical function as a primary endpoint, Elliott provided definitive evidence that minimally-invasive surgery significantly improves patient recovery—a finding that has directly influenced surgical guidelines and practice worldwide. This work exemplifies her commitment to evaluating surgical techniques through the lens of what matters most to patients. Elliott also contributes to the methodological rigor of surgical innovation, as seen in her protocol for the systematic review of transoral robotic surgery (2018), which addresses the critical need for transparent reporting in emerging technologies. Her research bridges the gap between technical surgical advances and meaningful patient outcomes, making her a vital voice in evidence-based surgery. For students and researchers, Elliott’s work demonstrates how well-designed trials can transform surgical care and improve quality of life for patients facing major cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2